Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

Similar articles for PubMed (Select 7323757)

1.

Prostatic carcinoma cured with hormonal treatment. A report of two cases.

Johansson S, Ljunggren E.

Scand J Urol Nephrol. 1981;15(3):321-2. No abstract available.

PMID:
7323757
2.

Polyestradiol phosphate and ethinyl estradiol in treatment of prostatic carcinoma.

Lindstedt E.

Scand J Urol Nephrol Suppl. 1980;55:95-7.

PMID:
6938044
3.

Hormonal pattern in prostatic cancer. II. Correlation with primary response to endocrine treatment.

Adlercreutz H, Rannikko S, Kairento AL, Karonen SL.

Acta Endocrinol (Copenh). 1981 Dec;98(4):634-40.

PMID:
7304086
4.
5.

Effects of estrogen treatment on human testicular unconjugated steroid and steroid sulfate production in vivo.

Leinonen P, Ruokonen A, Kontturi M, Vihko R.

J Clin Endocrinol Metab. 1981 Sep;53(3):569-73. No abstract available.

PMID:
7263840
9.

Tissue PSA is the best predicting variable for the outcome of endocrine treatment of prostatic carcinoma.

Pousette A, Grande M, Carlström K, Stege R.

Scand J Clin Lab Invest Suppl. 1999;229:27-32.

PMID:
10097287
11.

[Results of the treatment of prostatic cancer (author's transl)].

Takayasu H, Ogawa A, Koiso K, Komine Y, Ishii Y.

Nihon Hinyokika Gakkai Zasshi. 1978 Apr;69(4):426-35. Japanese. No abstract available.

PMID:
671900
12.

Carcinoma of the prostate. I. Histochemical examination as an aid in evaluating prostate carcinoma.

Vrubel F, Mráz J, Nĕmecek R, Papousek F, Hanselová M.

Int Urol Nephrol. 1979;11(4):295-9.

PMID:
536178
13.

Early results of the Finnish Multicentre Study of Prostatic Cancer (Finnprostate).

Haapiainen R, Rannikko S, Ruutu M, Ala-Opas M, Aro J, Ervasti J, Hansson E, Hurme K, Juusela H, Mäkinen J, et al.

Ann Chir Gynaecol. 1985;74(6):277-83.

PMID:
4096480
14.

[Thyroid hormones in metastasizing prostate cancer treated with polyestradiol phosphate].

Dunzendorfer U, Schulz H.

Z Urol Nephrol. 1982 Jul;75(7):493-500. German.

PMID:
6183845
15.

Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate.

Henriksson P, Eriksson A, Stege R, Collste L, Pousette A, von Schoultz B, Carlström K.

Prostate. 1988;13(3):257-61.

PMID:
3211807
16.
17.

[Long-term study of plasma testosterone levels in hormone therapy of prostatic cancer].

Hájek J, Hanselová M, Vrubel F.

Vnitr Lek. 1981 Sep;27(9):852-60. Czech. No abstract available.

PMID:
7293030
18.

Prostatic adenocarcinoma evolving into carcinoid: selective effect of hormonal treatment?

Stratton M, Evans DJ, Lampert IA.

J Clin Pathol. 1986 Jul;39(7):750-6.

19.

[Evaluation of cytomorphological parameters during hormonal therapy of prostatic carcinoma (author's transl)].

Keller AJ, Völter D, Bertsch H.

Urologe A. 1981 Jul;20(4):228-30. German.

PMID:
7196633
20.

Polyestradiol phosphate: a preliminary evaluation of its effect on breast carcinoma.

Ostrowski MJ, Jackson AW.

Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1803-7.

PMID:
393380
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk